Does DASATINIB Cause Product dose omission issue? 230 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 230 reports of Product dose omission issue have been filed in association with DASATINIB (dasatinib). This represents 0.8% of all adverse event reports for DASATINIB.
230
Reports of Product dose omission issue with DASATINIB
0.8%
of all DASATINIB reports
0
Deaths
27
Hospitalizations
How Dangerous Is Product dose omission issue From DASATINIB?
Of the 230 reports, 27 (11.7%) required hospitalization, and 1 (0.4%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DASATINIB. However, 230 reports have been filed with the FAERS database.
What Other Side Effects Does DASATINIB Cause?
Pleural effusion (2,424)
Fatigue (2,173)
Death (1,741)
Nausea (1,740)
Diarrhoea (1,728)
Headache (1,625)
Adverse event (1,382)
Rash (1,300)
Drug ineffective (1,271)
Hospitalisation (1,181)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which DASATINIB Alternatives Have Lower Product dose omission issue Risk?
DASATINIB vs DATOPOTAMAB DERUXTECAN-DLNK
DASATINIB vs DAUNORUBICIN
DASATINIB vs DAXIBOTULINUMTOXIN A-LANM
DASATINIB vs DAYTRANA
DASATINIB vs DECITABINE